Regeneron Logo.jpg
Three-year Results for EYLEA HD® (aflibercept) Injection 8 mg Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended Dosing Intervals in Patients with Diabetic Macular Edema
October 18, 2024 17:05 ET | Regeneron Pharmaceuticals, Inc.
88% of EYLEA HD patients had a last assigned dosing interval of ≥12 weeks at week 156, while sustaining visual and anatomic improvements achieved in the first 96 weeks, in this extension study of the...
GPM Logo.jpg
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sage Therapeutics, Inc. (SAGE)
October 18, 2024 12:00 ET | Glancy Prongay & Murray LLP
LOS ANGELES, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 28, 2024 deadline to file a lead plaintiff motion in the class action...
RAMSAY SANTE :Annual
RAMSAY SANTE :Annual results at the end of June 2024
October 18, 2024 11:35 ET | RAMSAY SANTE
PRESS RELEASE                 Paris, 18th October 2024 Annual results at the end of June 2024 As a mission-driven company, Ramsay Santé, thanks to its employees and medical community, is committed...
WRLG.png
West Red Lake Gold Announces Upsize To Previously Announced Bought Deal Public Offering
October 18, 2024 09:39 ET | West Red Lake Gold Mines Ltd.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- West Red Lake Gold Mines Ltd. (“West Red Lake Gold” or...
acme_logo.jpg
Acme United Reports 3% Increase in Net Income for Third Quarter of 2024
October 18, 2024 09:00 ET | Acme United Corporation
SHELTON, Conn., Oct. 18, 2024 (GLOBE NEWSWIRE) --  Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended September 30, 2024 were $48.2 million compared to...
BTTR-NEWLOGO-FINAL.jpg
UPDATE -- Better Choice Company Chairman Issues Letter to Shareholders as Company Continues to Make Progress Towards the Closing of its SRx Health Acquisition
October 18, 2024 07:49 ET | Better Choice Company Inc.
Combined company will emerge as a leading global health and wellness company by providing better products and solutions for pets, people, and families Combined 2025 revenue and EBITDA expected to be...
George Medicines Logo.JPG
Phase III trial results of novel triple combination pill for hypertension published in The Lancet
October 18, 2024 07:00 ET | George Medicines
Phase III trial results of novel triple combination pill for hypertension published in The Lancet Novel combination pill significantly reduced blood pressure and improved control rates vs dual...
NOVARTIS logo.jpg
Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer
October 18, 2024 06:47 ET | Novartis Pharma AG
If approved, patients in Europe with stage II or III HR+/HER2- early breast cancer (EBC) at high risk of recurrence, including those with node-negative disease, will be eligible for adjuvant treatment...
Figure 1
Calibre Announces Q3 & Year to Date 2024 Gold Production; Revises 2024 Guidance With Q4 Expected to Be the Strongest Production of the Year; Valentine Remains Fully Funded and On Track for Q2, 2025 Gold Production
October 18, 2024 06:00 ET | Calibre Mining Corp.
VANCOUVER, British Columbia, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (the "Company" or "Calibre") announces operating results for the three months (“Q3”) and...
BTTR-NEWLOGO-FINAL.jpg
Better Choice Company Chairman Issues Letter to Shareholders as Company Continues to Make Progress Towards the Closing of its SRx Health Acquisition
October 18, 2024 06:00 ET | Better Choice Company Inc.
Combined company will emerge as a leading global health and wellness company by providing better products and solutions for pets, people, and families Combined 2025 revenue and EBITDA expected to be...